What is OrbusNeich Medical Group Holdings EV-to-EBITDA?
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, OrbusNeich Medical Group Holdings's enterprise value is HK$1,235 Mil.
OrbusNeich Medical Group Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was HK$332 Mil. Therefore, OrbusNeich Medical Group Holdings's EV-to-EBITDA for today is 3.72.
The historical rank and industry rank for OrbusNeich Medical Group Holdings's EV-to-EBITDA or its related term are showing as below:
HKSE:06929'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 1.62 Med: 5.3 Max: 68.46
Current: 3.72
During the past 6 years, the highest EV-to-EBITDA of OrbusNeich Medical Group Holdings was 68.46. The lowest was 1.62. And the median was 5.30.
HKSE:06929's EV-to-EBITDA is ranked better than 89.84% of 492
companies
in the Medical Devices & Instruments industry
Industry Median: 15.18
vs HKSE:06929: 3.72
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
OrbusNeich Medical Group Holdings EV-to-EBITDA Chart
Competitive Comparison of OrbusNeich Medical Group Holdings's EV-to-EBITDA
For the Medical Instruments & Supplies subindustry, OrbusNeich Medical Group Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OrbusNeich Medical Group Holdings's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, OrbusNeich Medical Group Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where OrbusNeich Medical Group Holdings's EV-to-EBITDA falls into.
OrbusNeich Medical Group Holdings's current Enterprise Value is HK$1,235 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. OrbusNeich Medical Group Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was HK$332 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OrbusNeich Medical Group Holdings (HKSE:06929) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
OrbusNeich Medical Group Holdings's PE Ratio (TTM) for today is calculated as:
OrbusNeich Medical Group Holdings's share price for today is HK$3.79.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. OrbusNeich Medical Group Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.375.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
OrbusNeich Medical Group Holdings EV-to-EBITDA Related Terms
Thank you for viewing the detailed overview of OrbusNeich Medical Group Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
OrbusNeich Medical Group Holdings Business Description
OrbusNeich Medical Group Holdings Ltd is a China-based medical device maker of endovascular interventional instruments with majority reach. It launched its first research base in 2001 and was listed on the Hong Kong Exchange in 2022. As of 2023, OrbusNeich's majority revenue segment by geography is Japan with 24.7% of total revenue followed by Europe, the Middle East, and Africa, with 23.6% of total revenue. The Asia-Pacific region and the United States make up the balance. Its product segment is coronary interventional medical devices, such as scoring balloons, non-compliant balloons, or stents, together representing 82.7% of its total revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:06929 has been successfully added to your 